Skip to Content

Join the 'Bronchogenic Carcinoma' group to help and get support from people like you.

Bronchogenic Carcinoma News

Commitment Is Key for Online Quit-Smoking Groups

Posted 10 days ago by Drugs.com

MONDAY, Nov. 13, 2017 – An online social network designed to help you quit smoking can do just that, a new study finds. But the odds of quitting rise along with the level of active involvement, the researchers said. They examined the impact of BecomeAnEX.org, a social network site created by the nonprofit anti-tobacco group Truth Initiative, in collaboration with the Mayo Clinic. Network users can share information and support through blogs, forums and messages. More than 800,000 people have registered since the network was launched in 2008. The study included more than 2,600 smokers who signed up on BecomeAnEX.org. After three months, 21 percent of those who actively contributed content on the site had quit smoking, compared with 11 percent who only read others' posts and 8 percent of those who never visited the site. Researchers from the Truth Initiative and the University of Iowa ... Read more

Related support groups: Smoking, Smoking Cessation, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Nicorelief, Nicorette DS, Nicotrol NS, Bronchogenic Carcinoma, ProStep, Nicotrol TD

Survival Odds Improving for Lung Cancer Patients

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – In a finding that offers some hope to those fighting lung cancer, researchers report that survival rates have improved among those with early stage disease. "More and more patients are being cured of lung cancer, with both surgery and radiation as good treatment options," said study author Dr. Nirav Kapadia, from the Dartmouth-Hitchcock Medical Center in New Hampshire. "Our study optimistically suggests that if current trends persist, survival for [non-small-cell lung cancer] will continue to improve over time," he said. The study included more than 65,000 people diagnosed with stage 1 non-small-cell lung cancer between 2000 and 2010. Of that group, 62 percent had surgery, 15 percent received radiation therapy, 3 percent had both surgery and radiation and 18 percent received neither treatment. The two-year survival rate for people treated with either surgery ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma

Tighter Rules on Arsenic in Water Saved Lives: Study

Posted 23 Oct 2017 by Drugs.com

MONDAY, Oct. 23, 2017 – U.S. government limits on arsenic in drinking water has likely averted hundreds of cases of lung and bladder cancer annually, a new study suggests. After the Environmental Protection Agency introduced tighter limits on arsenic in public drinking water in 2006, there was a 17 percent decrease in levels of arsenic in the urine of people served by public water systems that complied with the rule, the researchers found. Not only that, but there were an estimated 200 fewer cases of lung and bladder cancer a year after the tougher rules were put in place. Levels of arsenic in the urine of people who used private wells did not change, according to the study published Oct. 23 in The Lancet Public Health journal. Arsenic is a carcinogen that naturally occurs in drinking water across the United States. The study findings highlight the important role that government ... Read more

Related support groups: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Skin Cancer, Bladder Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Trisenox, Arsenic Trioxide, Bronchogenic Carcinoma

Health Tip: Screening for Lung Cancer

Posted 4 Oct 2017 by Drugs.com

-- Lung cancer is one of the deadliest forms of cancer, and often lacks symptoms in its earliest stages. That's what makes lung cancer screening so important, the American Lung Association says. The organization provides this additional information: Screening can help find lung cancer at an early stage when it is easier to treat. A low (radiation) dose CT scan may reduce your chances of dying from lung cancer. This imaging process takes a series of pictures as you lie on a table that slides in and out of a scanning machine. Lung cancer screening is not suitable for everyone, but may be recommended for those at high risk for developing the disease. Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Diagnosis and Investigation, Bronchogenic Carcinoma

Switch From Smoking to Vaping Could Save Over 6 Million U.S. Lives

Posted 3 Oct 2017 by Drugs.com

MONDAY, Oct. 2, 2017 – Millions of cigarette smokers could live substantially longer if electronic cigarettes are embraced as a replacement for tobacco during the next decade, a new study contends. As many as 6.6 million cigarette smokers could live a combined 86.7 million more years under policies that encourage them to swap their smokes for e-cigarettes, according to "optimistic" projections from cancer researchers at Georgetown University in Washington, D.C. Even a worst-case scenario involving e-cigarettes would still save lives, the researchers said. Under a "pessimistic" projection, 1.6 million former cigarette smokers would have a combined 20.8 million more years of additional life, the research team found. These numbers show that adopting e-cigarettes as an alternative to smoking could prove the easiest way to cause tobacco use to dwindle in the United States, said lead ... Read more

Related support groups: Cough, Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Chronic Obstructive Pulmonary Disease, Acute, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Respiratory Tract Disease, Nicorelief, Nicorette DS, Nicotrol NS, ProStep

Radiation and Chemotherapy Together Boost Lung Cancer Survival

Posted 27 Sep 2017 by Drugs.com

TUESDAY, Sept. 26, 2017 – Combining radiation therapy with chemotherapy has substantially extended survival for many people with lung cancer, two new studies report. About 32 percent of non-small cell lung cancer patients who received chemoradiation therapy were still alive five years following treatment, a survival rate double that of previous estimates, according to results from a long-term clinical trial. Further, a small second clinical trial of people with lung cancer that had already spread to other parts of the body showed that radiation therapy added to chemo dramatically slowed the time until these cancers progressed further. The two studies show that radiation therapy and chemotherapy work well together, and that radiation also might help patients who are undergoing newer forms of cancer treatment like targeted therapy and immunotherapy, said Dr. Benjamin Movsas, a radiation ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, History - Radiation Therapy, Bronchogenic Carcinoma

HIV and Smoking a Lethal Combo for the Lungs

Posted 18 Sep 2017 by Drugs.com

MONDAY, Sept. 18, 2017 – HIV patients who take their medication but also smoke are about 10 times more likely to die from lung cancer than from AIDS-related causes, a new study estimates. Lifesaving antiretroviral drugs have improved life expectancy to the point that patients now have more to fear from tobacco than HIV, said lead researcher Dr. Krishna Reddy. "Thanks to antiretroviral medicines, people with HIV are living longer," said Reddy, a pulmonologist and critical care doctor with Massachusetts General Hospital in Boston. "The bad news is that they're living long enough to get cancer." Based on the new findings, smoking cessation should be a focus of treatment, he and his colleagues said. More than 40 percent of people with HIV are smokers, a rate more than double that of the general population, Reddy said. Fatalism and depression among HIV patients often lead them to take up ... Read more

Related support groups: Smoking, Smoking Cessation, HIV Infection, Nicotine, Lung Cancer, Pre-Exposure Prophylaxis, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Bronchogenic Carcinoma, Nicorelief, Nicorette DS, Nicotrol NS, ProStep, Nicotrol TD

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Anastrozole, Brain Tumor, Votrient, Letrozole

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Osteosarcoma, Melanoma, Ovarian Cancer, Endometrial Cancer, Pancreatic Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer, Breast Cancer, Prevention

Many With Advanced Lung Cancer Don't Get Treatments That Might Help

Posted 20 Jan 2017 by Drugs.com

FRIDAY, Jan. 20, 2017 – Many U.S. patients with late-stage lung cancer do not receive treatments that could prolong their lives, a new study finds. Researchers at the University of California, Davis Comprehensive Cancer Center analyzed 1998-2012 data from the U.S. National Cancer Database. They found that more than one in every five patients with non-small cell lung cancer (NSCLC) – by far the leading form of the disease – did not undergo any treatment. That included chemotherapy, radiotherapy or surgery, the researchers said. Many of the untreated patients were women, elderly, minorities, low-income and uninsured, according to the research team. The researchers found that the number of untreated patients with late-stage NSCLC even rose slightly during the study period. The reasons why some patients went untreated remain unclear, the researchers said. "We were able to identify a ... Read more

Related support groups: Surgery, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Merkel Cell Carcinoma, Malignant Pleural Effusion, Bronchogenic Carcinoma

Delaying Chemo After Lung Cancer Surgery? Better Late Than Never

Posted 6 Jan 2017 by Drugs.com

FRIDAY, Jan. 6, 2017 – Lung cancer chemotherapy that's been delayed due to slow recovery from surgery can still provide real benefit to patients, a new study suggests. The study involved thousands of patients with non-small-cell lung cancers (NSCLC), which comprise about 90 percent of all lung tumors. Lung cancer remains the leading cancer killer in the United States. As the study authors explained, chemotherapy is a standard part of treatment for people who've already had surgery to treat tumors that are larger than 4 centimeters (about 1.5 inches) or that have spread to the lymph nodes. Typically, this post-surgical chemotherapy begins within six weeks of the surgery. However, not all patients are able to tolerate chemotherapy so quickly after their operation, including those who develop surgical complications. So, a team led by Dr. Daniel Boffa, from the Yale School of Medicine, ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma

Smoking Wreaks Genetic Havoc on Lungs, Study Warns

Posted 4 Nov 2016 by Drugs.com

FRIDAY, Nov. 4, 2016 – Smoking is linked to significant genetic damage in the lungs and other organs of the body, according to new research. "This study offers fresh insights into how tobacco smoke causes cancer," said co-lead author Ludmil Alexandrov, the Oppenheimer Fellow at Los Alamos National Laboratory in New Mexico. "Our analysis demonstrates that tobacco smoking causes mutations that lead to cancer by multiple distinct mechanisms," he said in a Los Alamos news release. "Tobacco smoking damages DNA in organs directly exposed to smoke as well as speeds up a mutational cellular clock in organs that are both directly and indirectly exposed to smoke." In the study, researchers from Los Alamos, the Wellcome Trust Sanger Institute in England and other institutions analyzed more than 5,000 cancer tumors from smokers and nonsmokers. Cancer is caused by mutations in the DNA of a cell, ... Read more

Related support groups: Smoking, Smoking Cessation, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Diagnosis and Investigation, Bronchogenic Carcinoma

New Type of Radiation Treatment May Up Survival for Older Lung Cancer Patients

Posted 26 Sep 2016 by Drugs.com

MONDAY, Sept. 26, 2016 – Cutting-edge radiation therapy seems to provide a significant survival advantage for older people with early stage lung cancer who aren't strong enough for surgery, a pair of new studies suggests. The therapy is called stereotactic body radiation therapy (SBRT) and it's been available for about a decade. The first study reviewed national cancer data and found that survival rates for older lung cancer patients treated with radiation therapy increased dramatically between 2004 and 2012. Those are the years during which SBRT use became widespread in the United States, said lead researcher Dr. Andrew Farach, a radiation oncologist at Houston Methodist Hospital. A second study based on Veterans Affairs cancer treatment data appears to corroborate the national findings, directly linking increased use of SBRT with improved survival rates in elderly patients. Farach ... Read more

Related support groups: Surgery, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, History - Radiation Therapy, Bronchogenic Carcinoma

14 Genes That May Affect Cancer Treatment

Posted 31 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 31, 2016 – Researchers say they've identified 14 genes that may help determine whether a cancer treatment could help a patient. The researchers also say the findings suggest it could be possible to help people avoid unnecessary cancer treatments that won't likely benefit them. "The history of cancer treatment is filled with overreaction," said principal investigator Gary Karpen, a senior scientist at the U.S. Department of Energy's Lawrence Berkeley National Laboratory in Berkeley, Calif. "It is part of the ethics of cancer treatment to err on the side of overtreatment, but these treatments have serious side effects associated with them. For some people, it may be causing more trouble than if the growth was left untreated," Karpen said in a Berkeley Lab release. However, there has not been a reliable way to determine which early stage cancer patients will respond to ... Read more

Related support groups: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Diagnosis and Investigation, Bronchogenic Carcinoma

Smog May Shorten Lives of Lung Cancer Patients

Posted 5 Aug 2016 by Drugs.com

FRIDAY, Aug. 5, 2016 – Air pollution may shorten the lives of lung cancer patients, a new study suggests. Researchers led by Sandrah Eckel, who's with the department of preventive medicine at the University of Southern California in Los Angeles, analyzed data from more than 352,000 people in California who were diagnosed with lung cancer between 1988 and 2009. Higher exposure to the pollutants nitrogen dioxide, ozone and airborne particles was associated with an increased risk of early death. The association was strongest in patients with early stage disease, particularly adenocarcinoma, which accounts for 80 percent of lung cancer cases, the researchers said. Early stage patients with greater exposure to pollutants survived on average 2.4 years compared to 5.7 years for those with low exposure, the study found. The study was published online Aug. 4 in the journal Thorax. Since this ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Lung Cancer

Related Drug Support Groups

cimetidine, doxorubicin, Adriamycin, Adriamycin RDF, Adriamycin PFS